Astefor (NSAID)

Quick links to important sections

Astefor (NSAID)

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Astefor (NSAID)

Quick Facts

Property Description
Active ingredient Ibuprofen and Codeine
Form Oral Solid Dosage Form (Tablet)
Pharmacological class Combination Analgesic, NSAID
General purpose Enhanced relief of moderate pain
Origin Synthetic and Semi-synthetic
Regulatory Status (Astefor) Prescription-only (Codeine content)

What Type of Medicine is Astefor (NSAID)?

Astefor is classified as a fixed-dose combination medication for oral administration, belonging to the pharmacological class of Combination Analgesics. The formulation incorporates Ibuprofen, which establishes its primary identity as a Nonsteroidal Anti-inflammatory Drug (NSAID). This product configuration is distinct from monotherapies by utilizing two complementary mechanisms of action within a single tablet.

Due to the inclusion of Codeine, the final product is typically designated as a prescription-only medicine in many regulatory jurisdictions. Its market positioning is for patients whose pain intensity requires relief beyond that which standard, non-opioid, over-the-counter medications can provide.

Composition and Origin: The Dual Active Ingredients

The composition of Astefor is defined by the pairing of Ibuprofen and Codeine, both of which are chemically derived. Ibuprofen is a synthetically derived propionic acid compound, whereas Codeine is structurally a semi-synthetic derivative of morphine, classified as an opiate (narcotic) analgesic.

This deliberate combination is utilized for managing mild-to-moderate pain by pairing an NSAID like Ibuprofen with Codeine. The active substances are co-formulated with standard solid oral base/vehicle materials necessary for tablet manufacture.

General Purpose of the Codeine-Ibuprofen Combination

The fundamental purpose of Astefor is to provide symptomatic relief through synergistic action, a principle that indicates the combined effect is greater than the sum of the individual agents. This complementary action addresses discomfort by reducing peripheral inflammation via Ibuprofen while simultaneously modulating the central perception of pain via Codeine. Consequently, the combination is utilized to offer symptomatic relief for moderate discomfort that requires both anti-inflammatory action and a centrally mediated reduction in pain sensation.

Regulatory References

  1. NIH: Codeine, NBK526029

What side effects are possible with Astefor (NSAID)?

Possible Side Effects and Safety Information

Official regulatory documentation structures the safety profile of this combination medicine, which carries adverse reaction risks associated with both the Ibuprofen (NSAID) and the Codeine (Opioid) components. The most frequently observed adverse reactions, classified as Common, include drowsiness, dizziness, lightheadedness, sedation, nausea, vomiting, and sweating.


System-Organ Classes and Serious Reactions

Adverse events are documented across several System-Organ Classes, including the Gastrointestinal, Nervous, Respiratory, Cardiac, and Renal systems.

Regulatory documents emphasize the potential for Serious Adverse Reactions, which include major risks associated with the NSAID component, such as Gastrointestinal bleeding, ulceration, and perforation, and Cardiovascular thrombotic events (myocardial infarction or stroke). Risks related to the opioid component include potentially life-threatening respiratory depression.


Population and Duration Constraints

Specific Population-Specific Safety Considerations are noted in official labeling. The medicine is contraindicated in children under 12 years of age and in adolescents following tonsillectomy or adenoidectomy. There are also restrictions for use during pregnancy (avoided after 20 weeks) and lactation, as well as for individuals classified as CYP2D6 ultra-rapid metabolizers.

Duration-related safety patterns indicate that Prolonged Use increases the risk of drug dependence and abuse, in addition to serious renal and gastrointestinal adverse events. Furthermore, the medicine is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose of the combination medicine Astefor (Ibuprofen/Codeine) as presenting risks from both the Nonsteroidal Anti-inflammatory Drug (NSAID) component and the Opioid component.

Documented Overdose Manifestations

Component Documented Symptoms & Signs
Codeine (Opioid) Profound sedation, confusion, loss of consciousness, slow/shallow breathing, tiny pupils (miosis), and low blood pressure (hypotension).
Ibuprofen (NSAID) Severe stomach pain, nausea, vomiting, signs of gastrointestinal bleeding, and potential for acute kidney damage.

Serious Outcomes and Immediate Actions

Overdose from the opioid component is associated with a serious, life-threatening risk of fatal respiratory depression and coma. The NSAID component carries the risk of potentially fatal gastrointestinal perforation and cardiovascular events. Due to these severe outcomes, government regulatory guidance mandates that users must seek medical attention immediately upon suspected overdose, even if no symptoms are present. Individuals should call emergency services or a national Poison Help line right away.

Supportive Measures

Documented emergency management may include administering the opioid antagonist Naloxone to reverse the depressive effects. Further supportive measures described include providing breathing support (e.g., oxygen or ventilation) and the use of activated charcoal to limit absorption.

Therapeutic Uses of Astefor (NSAID)

What Astefor (Ibuprofen/Codeine) Treats: Main Uses and Benefits

The combination medicine Astefor is applied across domains where additional symptomatic support is needed, primarily for pain that creates noticeable physiological strain. It is applied when short-term symptomatic assistance is needed for moderate pain and is considered relevant in contexts involving heightened systemic burden.

It is commonly used across conditions presenting with acute episodes and helps address symptom clusters that may become intense or disruptive, including acute headaches (migraine), significant dental pain, pronounced backache, and severe period pain (dysmenorrhoea).


Enhanced Pain Relief for Moderate Acute Discomfort

This medication is used in situations involving certain distressing symptoms, generally applied in clinical settings that involve acute or unstable symptom patterns. The symptomatic support may assist with maintaining functional stability and contributes to easing the overall symptom load.

Symptomatic Management of Inflammatory Pain

Astefor is applied when symptoms relate to inflammatory or irritative states. This formulation may contribute to improved day-to-day comfort during periods of heightened symptoms in conditions like acute rheumatic or muscular pain and pain following traumatic injury.


QuickFact: Relief for Moderate Pain

Property Description
Primary Target Moderate pain in contexts requiring additional symptomatic support
Key Symptom Axes Physical discomfort, inflammatory states, acute changes
Patient Benefit Supports easing overall symptom load during difficult episodes
Typical Context Short-term management of episodic discomfort

Regulatory References

  1. Health Products Regulatory Authority

Eligibility and Restrictions for Use

Astefor, which contains the non-steroidal anti-inflammatory drug (NSAID) ibuprofen, is generally used by adults and adolescents for pain and inflammation management. Its suitability is dependent on an individual's medical history and existing conditions.


Can Use (General Indications)

Group Common Uses
Adults and Adolescents Mild to moderate pain, inflammation, fever, and symptoms of conditions like arthritis.

Cannot Use (Key Contraindications)

NSAIDs like ibuprofen are not appropriate for everyone and must be avoided in certain situations due to the risk of serious side effects. Consult a healthcare professional before use if you have, or have a history of, the following:

  • Allergy to ibuprofen, aspirin, or other NSAIDs.
  • Gastrointestinal Problems such as active stomach ulcers, bleeding, or perforation in the stomach or intestines.
  • Cardiovascular Conditions including severe heart failure, or a recent heart attack or stroke. NSAIDs may increase the risk of serious blood clotting events.
  • Kidney or Liver Failure (severe impairment).
  • Late Pregnancy (usually from 20 weeks onward) due to potential harm to the developing fetus.

Caution is also advised for older adults, individuals with high blood pressure, asthma, bleeding disorders, or those taking blood thinners or other NSAIDs.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Astefor (Ibuprofen/Codeine) documents interactions stemming from both active components, classified by the resulting clinical outcome.

Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated, with a mandatory 14-day washout period following cessation of MAOI therapy. The medicine is also strictly prohibited with other NSAIDs, including high-dose Aspirin or COX-2 selective inhibitors, and is contraindicated for pain management following Coronary Artery Bypass Graft (CABG) surgery.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Metabolic interactions occur via the Cytochrome P450 enzyme system. Co-administration with CYP2D6 inhibitors may reduce the plasma concentration of Codeine's active metabolite, resulting in reduced analgesic effect. Conversely, CYP3A4 inhibitors may increase Codeine plasma concentrations, raising the risk of opioid toxicity.

Pharmacodynamic interactions often involve additive risks. The Codeine component, when taken with CNS depressants (including alcohol), may enhance the risk of profound sedation and respiratory depression. The Ibuprofen component increases the risk of bleeding and GI ulceration when combined with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, or SSRIs.

Additionally, the Ibuprofen component may reduce the therapeutic effect of Antihypertensive Agents and may increase the plasma levels of certain medicines, including Lithium and Methotrexate.

Mechanism of Action

How Astefor (NSAID) Works

Astefor exerts its primary action by functioning as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes, targeting both the COX-1 and COX-2 isoforms. This interaction occurs at the enzyme's active site, blocking the key molecular step that converts arachidonic acid into various prostaglandins and other autocoids.

This fundamental disruption of the eicosanoid pathway limits the production of major prostaglandins, which function as inflammatory and pyretic mediators throughout the body. The drug's mechanism influences systems both peripherally and centrally. In peripheral tissues, reduced prostaglandin levels prevent the increased sensitivity of local receptors to stimuli. In the central nervous system, this mechanism modulates the hypothalamic temperature set-point, resulting in the physiological consequence of modifying an elevated body temperature.

This results in a diminished concentration of local inflammatory mediators, an increased activation threshold of peripheral nociceptors, and a modification of the central thermoregulatory set-point. This ultimately leads to functional alterations in defined physiological parameters.

Dosage and Administration Information

How to Use Astefor (Ibuprofen/Codeine) — Administration Guidelines

This section outlines the administration principles for Astefor (Ibuprofen 200 mg / Codeine 12.8 mg tablets), focusing on the procedural use of the medication.


Administration Scope

The medicine is designed exclusively for oral administration and is supplied as a film-coated tablet containing 200 mg of Ibuprofen and 12.8 mg of Codeine phosphate hemihydrate per unit. The tablets are taken by mouth with fluid and may be administered with food or milk to help minimize potential gastrointestinal discomfort.

Feature Administration Summary
Standard Single Dose One to two tablets.
Dosing Frequency Every 4 to 6 hours as required, maintaining a minimum four-hour interval between doses.
Maximum Daily Dose Do not exceed 6 tablets in 24 hours.

Labeled Duration and Population Rules

Established parameters limit the treatment duration to the shortest period of time necessary to manage symptoms, with a total maximum use of three consecutive days. The use of Astefor is not permitted in children under 12 years of age. For adolescents aged 12 to 18 years, the dosing regimen is the same as the adult regimen (1 to 2 tablets every 4 to 6 hours), provided the maximum daily and duration limits are observed. A critical co-medication constraint is explicitly stated: the tablets must not be taken concurrently with any other product containing codeine or other opioids.


Connection to the Overall Use Protocol

These instructions establish a structured, interval-based approach to using the medicine, defined by a specific minimum time between doses and a strict quantity ceiling. This framework mandates short-term use and governs the procedural steps for administration, ensuring adherence to the critical maximum daily and overall duration limits.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase III Clinical Trials

Large-scale, randomized studies examined the compound in individuals diagnosed with [Condition X]. These trials, according to the research, evaluated whether the compound was associated with changes in quality of life and the symptoms often associated with [Condition X].

  • Study Design: Most trials were double-blind, placebo-controlled, and involved over 1,000 participants globally.
  • Key Findings: Primary outcomes focused on changes in the [Specific Measure A] score and the recording of the frequency of [Symptom B]. Research data assessed changes in symptoms over time, including during the initial phase of administration.

Biological Focus

Studies have focused on the compound’s impact on biological markers, including inflammation markers and the [Target Receptor] in the [Specific Organ].

  • Focus Areas: Research investigated the compound’s impact on [Biomarker Z] levels. Studies did not evaluate the effect of discontinuing the compound in participants.

Emerging Research and Other Conditions

Research is ongoing to understand the full potential scope of the compound. Research is examining the use of the compound in individuals with [Condition Y], which shares certain immunological markers with [Condition X].

  • Investigated Use in [Condition Y]: Several smaller, open-label trials have explored the use of the compound in individuals diagnosed with [Condition Y]. These trials primarily measured the occurrence of adverse events in this new population.
  • Combination Therapies: Research investigated the co-administration of the compound with [Drug Y] and recorded corresponding changes in relevant biomarkers. Some studies compared outcomes for the compound versus earlier-developed compounds.

Long-Term Observational Data

Long-term observational data examined the health status of individuals who used the compound for more than 5 years. These studies aim to document sustained outcomes and monitor for potential late-emerging effects. The data is retrospective and non-controlled, limiting definitive causal conclusions.

Key Studies & References

  1. Mechanism of Action of Nonsteroidal Anti-Inflammatory Drugs (Detailed Mechanistic/Biological Review)

Frequently Asked Questions (FAQ)

Common questions about Astefor (NSAID) (FAQ)


Q: How quickly does Astefor usually start to work after taking it?

A: According to official product information, the Ibuprofen component is absorbed rapidly from the digestive system. The Codeine component typically reaches its peak concentration in the bloodstream about one hour after the medicine is ingested.

Q: Can taking Astefor make you feel drowsy or tired?

A: Regulatory documents classify both drowsiness and sedation as commonly observed side effects associated with the use of this medicine. Official warnings state that people who experience these effects must refrain from driving or operating machinery.

Q: Can Astefor cause changes in mood or anxiety?

A: Official warnings note that the medicine may affect the central nervous system. Due to this effect, caution is advised for people with a history of depression or other mental health problems. This is noted as a caution due to the medicine's effects on the central nervous system.

Q: Does taking Astefor with food help reduce side effects?

A: Official administration instructions state that the drug may be administered with food or milk. This practice is intended to help minimize the potential for gastrointestinal discomfort, which is a known side effect of the Ibuprofen component.

Q: What is the typical duration of pain relief expected from one dose of Astefor?

A: The standard administration frequency noted in official documents is every four to six hours. The four to six hour interval reflects the minimum time between doses, which relates to the duration of the medicine’s concentration in the body.

Q: What is the official guidance on consuming alcohol while using Astefor?

A: Official warnings state that consuming alcoholic beverages while using this medicine is associated with increased risk of side effects. Alcohol can increase the risk of adverse events associated with the Codeine component, such as dizziness, poor concentration, and drowsiness.

Q: Why are people with existing kidney problems cautioned about using Astefor?

A: The Ibuprofen component (an NSAID) is associated with effects on kidney function. Caution is advised, and the medicine is contraindicated (prohibited for use) in cases of severe kidney impairment due to the risk of serious kidney problems.

Q: Can Astefor cause fluid retention or swelling?

A: Official information notes that the Ibuprofen component may be associated with fluid retention and edema (swelling). This effect relates to the way NSAIDs influence certain body functions, such as prostaglandin synthesis.

Q: Can Astefor interact with drugs used to treat depression?

A: Yes, regulatory documents indicate that the medicine may interact with certain drugs used for depression, such as Selective Serotonin Reuptake Inhibitors (SSRIs). These combinations may potentially increase the risk of adverse events like bleeding or enhancing central nervous system effects.

Q: Is Astefor the same kind of drug as ibuprofen or naproxen?

A: Astefor is a combination medicine that contains Ibuprofen (an NSAID) and Codeine (an opioid). It is not the same as taking a single NSAID tablet. Official documents explicitly prohibit taking the medicine with other NSAID products or products containing Codeine.

Q: Can Astefor be used for long-term conditions?

A: Regulatory instructions strictly limit the total maximum treatment duration to the shortest period of time necessary, with a maximum use of three consecutive days. This limitation is based on regulatory constraints regarding the use of opioid analgesics.

Q: Is Astefor known to be addictive?

A: The Codeine component in the medicine may be habit forming. Official warnings indicate that prolonged use of the medicine can lead to physical dependence and addiction.

Q: Is a metallic taste in the mouth reported as a side effect of Astefor?

A: While not listed among the most commonly observed effects, the active ingredient Ibuprofen belongs to a class of medicines that have been reported to cause changes in taste or an unpleasant or altered taste.

Q: Are there any major diet restrictions when taking Astefor?

A: Official documents advise against consuming alcoholic beverages while using this medicine due to safety risks. The medicine may be taken with food, but no other major diet restrictions are typically specified in regulatory documents.

Q: Can Astefor be taken with over-the-counter cold and flu medicine?

A: Official documents caution against co-administration with many cold and flu remedies. This is because the medicine must not be taken with any other product containing Codeine or other opioids or with other NSAIDs, which are often found in these products.

Q: What are the limitations on using Astefor in older adults?

A: Older adults require caution during the use of this medicine. Caution is required because older adults are documented to be at increased risk for serious adverse events, including gastrointestinal and cardiovascular risks.

Q: What should be done if someone accidentally takes too much Astefor?

A: Official guidance indicates that signs of an overdose require immediate medical attention. Symptoms may include difficulty breathing, slow or shallow breathing, excessive sleepiness, or being unable to respond or wake up.

Q: Can people with stomach ulcers use Astefor under any circumstances?

A: The medicine is contra-indicated (prohibited for use) for patients with active stomach ulcers, bleeding, or perforation. Patients with a prior history of peptic ulcer disease are officially noted to be at greater risk for serious adverse events.

Q: Is it common to have headaches when first starting Astefor?

A: Headache is listed in the official documents as a possible, non-serious side effect. This is noted as a possible side effect in the medicine’s safety profile.

Q: Are there any known interactions between Astefor and herbal supplements?

A: Official regulatory documents state that it is not possible to confirm safety with herbal remedies and supplements. This is because these products are generally not tested for their specific effect on this medicine.

Q: Is it normal to feel nauseous when starting Astefor?

A: Nausea and vomiting are listed in official documents as commonly observed side effects. The product information notes that taking the medicine with food or milk is a method used to help minimize potential gastrointestinal discomfort.

Q: Does Astefor impact a person's ability to drive or operate machinery?

A: Due to the potential risk of side effects such as drowsiness and dizziness, official documents include a warning that individuals who experience these effects must refrain from driving or operating machinery.

Q: What are the official recommendations regarding taking Astefor before surgery?

A: The medicine is strictly contraindicated for pain management following Coronary Artery Bypass Graft (CABG) surgery. For general elective surgery, stopping the Ibuprofen component (NSAID) pre-operatively involves a risk assessment due to potential bleeding risk.

Q: What is the chemical name for the active ingredient in Astefor?

A: The active ingredients are Ibuprofen and Codeine. Ibuprofen is a propionic acid derivative, and Codeine is chemically referred to as Methylmorphine.

Q: How are the side effects of Astefor monitored in clinical studies?

A: Regulatory bodies monitor the safety of medicines through comprehensive systems known as pharmacovigilance. For example, the European Medicines Agency (EMA) uses a single repository called EudraVigilance to manage and analyze information on suspected adverse reactions seen in healthcare practice and clinical trials.

Q: What kind of studies were conducted to get Astefor approved?

A: The approval process requires evidence from controlled human studies, including Phase III clinical trials. These trials often involve large, randomized, double-blind, placebo-controlled designs that evaluate patient symptoms and the occurrence of adverse events.

Q: Is Astefor used for conditions not related to pain, such as inflammation?

A: Yes, the Ibuprofen component (NSAID) works by reducing peripheral inflammation and fever, in addition to providing pain relief. This dual mechanism addresses both pain perception and inflammatory processes.

Q: What happens in the body when Astefor starts working?

A: The Ibuprofen component works by reducing the production of prostaglandins, which are substances in the body that cause inflammation and fever. The Codeine component simultaneously works in the central nervous system to change how the brain perceives the pain sensation.

Q: Are there specific instructions for stopping Astefor after long-term use?

A: Due to the risk of physical dependence with prolonged use, official guidance suggests that when therapy is no longer required, the dose should be tapered gradually. This approach is intended to minimize potential symptoms of withdrawal.

How should Astefor (NSAID) be stored and disposed of?

How to Store and Dispose of Astefor (Ibuprofen and Codeine)

Official regulatory guidelines for Astefor (Ibuprofen and Codeine) require storage at a temperature below 25°C (77°F), and the medication must be kept in its original package, protected from light.

Security and Child Protection

Due to the presence of the opioid codeine, the tablets must be stored in a secure place and kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Astefor should be disposed of through a drug take-back program whenever possible, as this is the preferred method for controlled substances. Disposal via wastewater or general household waste should be avoided unless explicitly directed otherwise by a regulatory body. All disposal must comply with local waste requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Astefor (NSAID) found in:

A-Z Index: